Tag: metabolic

Picture Gallery Venture Capital

Ritter Pharmaceuticals Announces Phase 3 Plans after its End of Phase 2 Meeting with FDA on RP-G28 for Lactose Intolerance

August 18, 2017
Presse

Company has incorporated guidance from FDA on key elements of its Phase 3 program to support…

Continue Reading